Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.41 |
| ▸ | HRH2 | P25021 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1494479 | 0.98 | SMN1; SMN2 (0.64) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL9937405 | 0.96 | SMN1; SMN2 (0.62) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| Hydrochloric Acid SCHEMBL27554302 | 0.96 | SMN1; SMN2 (0.62) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL5865021 | 0.92 | CYP1A2 (0.57) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL27793739 | 0.92 | CYP1A2 (0.57) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL5015980 | 0.91 | CYP1A2 (0.53) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL4961439 | 0.91 | CXCR4 (0.68) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL21727957 | 0.90 | CYP1A2 (0.55) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL9154884 | 0.90 | CYP1A2 (0.55) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 | |
| SCHEMBL11429662 | 0.90 | CYP1A2 (0.55) | SMN1; SMN2CYP1A2MAPK1CXCR4SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1741450-B1 | COMPOSITION FOR MEDICAL USE HAVING IMPROVED WATER-SOLUBILITY OF PEPTIDE AND METAL-LABELING EFFICIENCY AND PREPARATION FOR MEDICAL USE COMPRISING METAL-LABELED PEPTIDE | NIHON MEDIPHYSICS CO LTD (JP) | 2013-12-11 | — | — | EP | claimed |
| US-20070160532-A1 | Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-07-12 | — | — | US | claimed |
| EP-1741450-A1 | COMPOSITION FOR MEDICAL USE HAVING IMPROVED WATER-SOLUBILITY OF PEPTIDE AND METAL-LABELING EFFICIENCY AND PREPARATION FOR MEDICAL USE COMPRISING METAL-LABELED PEPTIDE | Nihon Medi-Physics Co., Ltd. (JP) | 2007-01-10 | — | — | EP | claimed |
| EP-1741450-B1 | COMPOSITION FOR MEDICAL USE HAVING IMPROVED WATER-SOLUBILITY OF PEPTIDE AND METAL-LABELING EFFICIENCY AND PREPARATION FOR MEDICAL USE COMPRISING METAL-LABELED PEPTIDE | NIHON MEDIPHYSICS CO LTD (JP) | 2013-12-11 | — | — | EP | disclosed |
| US-7854918-B2 | Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-12-21 | — | — | US | disclosed |
| EP-1548027-B1 | COMPOUND BINDING TO LEUKOCYTES AND MEDICINAL COMPOSITION CONTAINING THE COMPOUND IN LABELED STATE AS THE ACTIVE INGREDIENT | NIHON MEDIPHYSICS CO LTD (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070160532-A1 | Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-07-12 | — | — | US | disclosed |
| US-7220827-B2 | Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| EP-1741450-A1 | COMPOSITION FOR MEDICAL USE HAVING IMPROVED WATER-SOLUBILITY OF PEPTIDE AND METAL-LABELING EFFICIENCY AND PREPARATION FOR MEDICAL USE COMPRISING METAL-LABELED PEPTIDE | Nihon Medi-Physics Co., Ltd. (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-20060057064-A1 | Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2006-03-16 | — | — | US | disclosed |
| CN-1684973-A | Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient | NIHON MEDIPHYSICS CO LTD (JP) | 2005-10-19 | — | — | CN | disclosed |
| EP-1548027-A1 | COMPOUND BINDING TO LEUKOCYTES AND MEDICINAL COMPOSITION CONTAINING THE COMPOUND IN LABELED STATE AS THE ACTIVE INGREDIENT | Nihon Medi-Physics Co., Ltd. (JP) | 2005-06-29 | — | — | EP | disclosed |